A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/4164 (2006.01) A61K 31/415 (2006.01) A61P 25/00 (2006.01)
Patent
CA 2251949
The invention relates to the treatment of Attention Deficit Hyperactivity Disorder (ADHD). Lofexidine is used for control of ADHD. Typical doses are from 0.005 to 0.02 mg/kg.
Cette invention concerne le traitement de l'hyperactivité avec déficit de l'attention (HDA). On utilise de la lofexidine pour réguler la HDA. Les doses courantes varient entre 0,005 et 0,02 mg/kg.
Arnsten Amy
Davies Keith
Britannia Pharmaceuticals Limited
Moffat & Co.
LandOfFree
Use of lofexidine in the manufacture of a medicament for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of lofexidine in the manufacture of a medicament for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of lofexidine in the manufacture of a medicament for... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1368785